Rocksolid Light

News from da outaworlds

mail  files  register  groups  login

Message-ID:  

You will be a winner today. Pick a fight with a four-year-old.


sci / sci.med.pathology / Iron Chelation In Cancer

SubjectAuthor
o Iron Chelation In Cancerironjustice

1
Subject: Iron Chelation In Cancer
From: ironjustice
Newsgroups: sci.med.pathology
Date: Sun, 1 Aug 2021 02:48 UTC
X-Received: by 2002:a05:620a:a5a:: with SMTP id j26mr9394825qka.42.1627786082483; Sat, 31 Jul 2021 19:48:02 -0700 (PDT)
X-Received: by 2002:a05:6808:aa3:: with SMTP id r3mr6661534oij.133.1627786082136; Sat, 31 Jul 2021 19:48:02 -0700 (PDT)
Path: eternal-september.org!news.eternal-september.org!reader01.eternal-september.org!reader02.eternal-september.org!news.uzoreto.com!tr1.eu1.usenetexpress.com!feeder.usenetexpress.com!tr2.iad1.usenetexpress.com!border1.nntp.dca1.giganews.com!nntp.giganews.com!news-out.google.com!nntp.google.com!postnews.google.com!google-groups.googlegroups.com!not-for-mail
Newsgroups: sci.med.pathology
Date: Sat, 31 Jul 2021 19:48:01 -0700 (PDT)
Injection-Info: google-groups.googlegroups.com; posting-host=2001:56a:723e:aa00:bcac:d418:a49f:e5af; posting-account=hBAG4AoAAABOaauYJdMbCKnI-qYy_97e
NNTP-Posting-Host: 2001:56a:723e:aa00:bcac:d418:a49f:e5af
User-Agent: G2/1.0
MIME-Version: 1.0
Message-ID: <27e4d549-b122-486c-bdc4-a0644e432935n@googlegroups.com>
Subject: Iron Chelation In Cancer
From: teamtanner@hotmail.com (ironjustice)
Injection-Date: Sun, 01 Aug 2021 02:48:02 +0000
Content-Type: text/plain; charset="UTF-8"
Content-Transfer-Encoding: quoted-printable
Lines: 53
View all headers

Reversing oncogenic transformation with iron chelation
Oncotarget. 2021; 12:106-124. https://doi.org/10.18632/oncotarget.27866
Gina Abdelaal1 and Stephany Veuger1
1 Department of Applied Sciences, Faculty of Health and Life Sciences, Northumbria University, Newcastle upon Tyne, UK
Gina Abdelaal, email: gina.abdelaal @ northumbria.ac.uk
Received: September 29, 2020     Accepted: December 16, 2020     Published: January 19, 2021

ABSTRACT
Cancer cells accumulate iron to supplement their aberrant growth and metabolism. Depleting cells of iron by iron chelators has been shown to be selectively cytotoxic to cancer cells in vitro and in vivo. Iron chelators are effective at combating a range of cancers including those which are difficult to treat such as androgen insensitive prostate cancer and cancer stem cells. This review will evaluate the impact of iron chelation on cancer cell survival and the underlying mechanisms of action. A plethora of studies have shown iron chelators can reverse some of the major hallmarks and enabling characteristics of cancer. Iron chelators inhibit signalling pathways that drive proliferation, migration and metastasis as well as return tumour suppressive signalling. In addition to this, iron chelators stimulate apoptotic and ER stress signalling pathways inducing cell death even in cells lacking a functional p53 gene. Iron chelators can sensitise cancer cells to PARP inhibitors through mimicking BRCAness; a feature of cancers trademark genomic instability. Iron chelators target cancer cell metabolism, attenuating oxidative phosphorylation and glycolysis. Moreover, iron chelators may reverse the major characteristics of oncogenic transformation. Iron chelation therefore represent a promising selective mode of cancer therapy.
Keywords: iron chelator; oncogenesis; selective cytotoxicity; hallmarks of cancer; NDRG1

https://www.oncotarget.com/article/27866/text/

Copyright: © 2021 Abdelaal and Veuger. This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Who loves ya.
Tom

Jesus Was A Vegetarian!
http://tinyurl.com/2r2nkh

Man Is A Herbivore!
http://tinyurl.com/4rq595

DEAD PEOPLE WALKING
http://tinyurl.com/zk9fk

1

rocksolid light 0.9.8
clearnet tor